Prostate Cancer Aggressiveness
Oncology·MeSH: Prostate Cancer, Hereditary, 7
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Olaparib | Janux Therapeutics, Inc. (JANX) |
Frequently asked questions
How many drugs are in development for Prostate Cancer Aggressiveness?
BioSniper tracks 1 drug in development for Prostate Cancer Aggressiveness across 1 company.
How many clinical trials target Prostate Cancer Aggressiveness?
There are 2 clinical trials targeting Prostate Cancer Aggressiveness tracked by BioSniper.
What is the prevalence of Prostate Cancer Aggressiveness?
The estimated prevalence of Prostate Cancer Aggressiveness is approximately 256.0 per 100,000 population.
Deep-dive into Prostate Cancer Aggressiveness
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis